FreeMind: biOasis Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

VANCOUVER, BC-(Marketwired - June 15, 2017) - biOasis Technologies Inc. (OTCQB: BIOAF) (TSX VENTURE: BTI) announced today it has engaged FreeMind Group to assist the Company pursue non-dilutive funding opportunities globally. The biOasis Transcend technology has been demonstrated to transport several different drug modalities (e.g., antibodies, enzymes, small molecules) across the blood-brain barrier (BBB) and ...